XML 41 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Shareholders' Equity (Tables) | 3 Months Ended
--- | ---
Mar. 30, 2025
Equity [Abstract] |
Schedule of Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share:
|  |  |  | Three Months Ended
|  |  |  |  |  | March 30, 2025 |  | March 31, 2024
Numerator: |  |  |  |  |  |  |  |
Net income from continuing operations |  |  |  |  |  | $ | 49,317 |  |  | $ | 35,512 |
Net income from continuing operations attributable to noncontrolling interests |  |  |  |  |  | (60) |  |  | (48) |
Net income from continuing operations attributable to Sonoco |  |  |  |  |  | 49,257 |  |  | 35,464 |
Net income attributable to Sonoco |  |  |  |  |  | $ | 54,429 |  |  | $ | 65,177 |
Denominator: |  |  |  |  |  |  |  |
Weighted average common shares outstanding |  |  |  |  |  | 98,913 |  |  | 98,498 |
Dilutive effect of shared-based compensation |  |  |  |  |  | 429 |  |  | 661 |
Diluted outstanding shares |  |  |  |  |  | 99,342 |  |  | 99,159 |
Per common share: |  |  |  |  |  |  |  |
Basic earnings per common share: |  |  |  |  |  |  |  |
Net income from continuing operations |  |  |  |  |  | $ | 0.50 |  |  | $ | 0.36 |
Net income attributable to Sonoco |  |  |  |  |  | $ | 0.55 |  |  | $ | 0.66 |
Diluted earnings per common share: |  |  |  |  |  |  |  |
Net income from continuing operations |  |  |  |  |  | $ | 0.50 |  |  | $ | 0.36 |
Net income attributable to Sonoco |  |  |  |  |  | $ | 0.55 |  |  | $ | 0.66 |
Cash dividends |  |  |  |  |  | $ | 0.52 |  |  | $ | 0.51 |
Schedule of Antidilutive Securities | The average numbers of SARs that were anti-dilutive and, therefore, not included in the computation of diluted earnings per share during the three-month periods ended March 30, 2025 and March 31, 2024 were as follows (in thousands):
|  |  |  | Three Months Ended
|  |  |  |  |  | March 30, 2025 |  | March 31, 2024
Anti-dilutive stock appreciation rights |  |  |  |  |  | 548 |  |  | 340 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration